Efficiency and Safety of Long-Term Artrofoon Treatment in Rheumatoid Arthritis

In patients with rheumatoid arthritis, prolongation of artrofoon therapy to 2 years led to maintenance of the positive clinical effect attained after 6-month treatment. Moreover, significant improvement was observed by some parameters (integral pain intensity, swelling index, Ritchie articular index...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of experimental biology and medicine 2009-09, Vol.148 (3), p.486-488
Main Authors: Petrov, V. I, Babaeva, A. R, Cherevkova, E. V, Kachanova, M. V, Zabolotneva, Yu. A, Tarasov, S. A, Dugina, Yu. L, Sergeeva, S. A
Format: Article
Language:English
Subjects:
Adult
Aged
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Antirheumatic Agents - adverse effects
Antirheumatic Agents - therapeutic use
Arthritis, Rheumatoid - drug therapy
artrofoon
Biomedical and Life Sciences
Biomedicine
Cell Biology
Female
Humans
Internal Medicine
Laboratory Medicine
Male
Middle Aged
Pathology
proinflammatory cytokines
rheumatoid arthritis
Treatment Outcome
tumor necrosis factor-a
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c346t-aa92b9219857a868d30d83808318acbea38550dd451cc02ba522860c317b8bd33
container_end_page 488
container_issue 3
container_start_page 486
container_title Bulletin of experimental biology and medicine
container_volume 148
creator Petrov, V. I
Babaeva, A. R
Cherevkova, E. V
Kachanova, M. V
Zabolotneva, Yu. A
Tarasov, S. A
Dugina, Yu. L
Sergeeva, S. A
description In patients with rheumatoid arthritis, prolongation of artrofoon therapy to 2 years led to maintenance of the positive clinical effect attained after 6-month treatment. Moreover, significant improvement was observed by some parameters (integral pain intensity, swelling index, Ritchie articular index, morning stiffness, and articular score). No side effects related to artrofoon treatment were observed throughout the treatment period in the main group. The results indicate high efficiency and good tolerability of the preparation and attest to advisability of its long-term use.
doi_str_mv 10.1007/s10517-010-0743-4
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733890996</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1964606521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c346t-aa92b9219857a868d30d83808318acbea38550dd451cc02ba522860c317b8bd33</originalsourceid><addsrcrecordid>eNp9kMFO3DAQhq2qqCy0D9BLG_XCyTBjJ7F9RAhopRVIsJwtx3EWo41N7eSwb1-vQluph56skb__n9FHyGeEcwQQFxmhQUEBgYKoOa3fkRU2glPJGL4nKygQraWUx-Qk55fDCC1-IMcMuGoFqhW5ux4Gb70Ldl-Z0FePZnDTvopDtY5hSzcujdVlmlIcYgzVJjkzjS5MlQ_Vw7ObRzNF3x-I5-Qnnz-So8Hssvv09p6Sp5vrzdV3ur6__XF1uaaW1-1EjVGsUwyVbISRrew59JJLkBylsZ0zXDYN9H3doLXAOtMwJluwHEUnu57zU3K29L6m-HN2edKjz9btdia4OGctOJcKlGoL-e0f8iXOKZTjNMNCta0SBcIFsinmnNygX5MfTdprBH1QrRfVuqjWB9W6Lpkvb8VzN7r-T-K32wKwBcjlK2xd-rv5f61fl9Bgojbb5LN-emSAHFACh1L-C84JkHE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213386697</pqid></control><display><type>article</type><title>Efficiency and Safety of Long-Term Artrofoon Treatment in Rheumatoid Arthritis</title><source>Springer Link</source><creator>Petrov, V. I ; Babaeva, A. R ; Cherevkova, E. V ; Kachanova, M. V ; Zabolotneva, Yu. A ; Tarasov, S. A ; Dugina, Yu. L ; Sergeeva, S. A</creator><creatorcontrib>Petrov, V. I ; Babaeva, A. R ; Cherevkova, E. V ; Kachanova, M. V ; Zabolotneva, Yu. A ; Tarasov, S. A ; Dugina, Yu. L ; Sergeeva, S. A</creatorcontrib><description>In patients with rheumatoid arthritis, prolongation of artrofoon therapy to 2 years led to maintenance of the positive clinical effect attained after 6-month treatment. Moreover, significant improvement was observed by some parameters (integral pain intensity, swelling index, Ritchie articular index, morning stiffness, and articular score). No side effects related to artrofoon treatment were observed throughout the treatment period in the main group. The results indicate high efficiency and good tolerability of the preparation and attest to advisability of its long-term use.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-010-0743-4</identifier><identifier>PMID: 20396719</identifier><identifier>CODEN: BEXBAN</identifier><language>eng</language><publisher>Boston: Boston : Springer US</publisher><subject>Adult ; Aged ; Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal - therapeutic use ; Antirheumatic Agents - adverse effects ; Antirheumatic Agents - therapeutic use ; Arthritis, Rheumatoid - drug therapy ; artrofoon ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Female ; Humans ; Internal Medicine ; Laboratory Medicine ; Male ; Middle Aged ; Pathology ; proinflammatory cytokines ; rheumatoid arthritis ; Treatment Outcome ; tumor necrosis factor-a</subject><ispartof>Bulletin of experimental biology and medicine, 2009-09, Vol.148 (3), p.486-488</ispartof><rights>Springer Science+Business Media, Inc. 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c346t-aa92b9219857a868d30d83808318acbea38550dd451cc02ba522860c317b8bd33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20396719$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Petrov, V. I</creatorcontrib><creatorcontrib>Babaeva, A. R</creatorcontrib><creatorcontrib>Cherevkova, E. V</creatorcontrib><creatorcontrib>Kachanova, M. V</creatorcontrib><creatorcontrib>Zabolotneva, Yu. A</creatorcontrib><creatorcontrib>Tarasov, S. A</creatorcontrib><creatorcontrib>Dugina, Yu. L</creatorcontrib><creatorcontrib>Sergeeva, S. A</creatorcontrib><title>Efficiency and Safety of Long-Term Artrofoon Treatment in Rheumatoid Arthritis</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>In patients with rheumatoid arthritis, prolongation of artrofoon therapy to 2 years led to maintenance of the positive clinical effect attained after 6-month treatment. Moreover, significant improvement was observed by some parameters (integral pain intensity, swelling index, Ritchie articular index, morning stiffness, and articular score). No side effects related to artrofoon treatment were observed throughout the treatment period in the main group. The results indicate high efficiency and good tolerability of the preparation and attest to advisability of its long-term use.</description><subject>Adult</subject><subject>Aged</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antirheumatic Agents - adverse effects</subject><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>artrofoon</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Female</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pathology</subject><subject>proinflammatory cytokines</subject><subject>rheumatoid arthritis</subject><subject>Treatment Outcome</subject><subject>tumor necrosis factor-a</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kMFO3DAQhq2qqCy0D9BLG_XCyTBjJ7F9RAhopRVIsJwtx3EWo41N7eSwb1-vQluph56skb__n9FHyGeEcwQQFxmhQUEBgYKoOa3fkRU2glPJGL4nKygQraWUx-Qk55fDCC1-IMcMuGoFqhW5ux4Gb70Ldl-Z0FePZnDTvopDtY5hSzcujdVlmlIcYgzVJjkzjS5MlQ_Vw7ObRzNF3x-I5-Qnnz-So8Hssvv09p6Sp5vrzdV3ur6__XF1uaaW1-1EjVGsUwyVbISRrew59JJLkBylsZ0zXDYN9H3doLXAOtMwJluwHEUnu57zU3K29L6m-HN2edKjz9btdia4OGctOJcKlGoL-e0f8iXOKZTjNMNCta0SBcIFsinmnNygX5MfTdprBH1QrRfVuqjWB9W6Lpkvb8VzN7r-T-K32wKwBcjlK2xd-rv5f61fl9Bgojbb5LN-emSAHFACh1L-C84JkHE</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Petrov, V. I</creator><creator>Babaeva, A. R</creator><creator>Cherevkova, E. V</creator><creator>Kachanova, M. V</creator><creator>Zabolotneva, Yu. A</creator><creator>Tarasov, S. A</creator><creator>Dugina, Yu. L</creator><creator>Sergeeva, S. A</creator><general>Boston : Springer US</general><general>Springer US</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20090901</creationdate><title>Efficiency and Safety of Long-Term Artrofoon Treatment in Rheumatoid Arthritis</title><author>Petrov, V. I ; Babaeva, A. R ; Cherevkova, E. V ; Kachanova, M. V ; Zabolotneva, Yu. A ; Tarasov, S. A ; Dugina, Yu. L ; Sergeeva, S. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c346t-aa92b9219857a868d30d83808318acbea38550dd451cc02ba522860c317b8bd33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antirheumatic Agents - adverse effects</topic><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>artrofoon</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Female</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pathology</topic><topic>proinflammatory cytokines</topic><topic>rheumatoid arthritis</topic><topic>Treatment Outcome</topic><topic>tumor necrosis factor-a</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Petrov, V. I</creatorcontrib><creatorcontrib>Babaeva, A. R</creatorcontrib><creatorcontrib>Cherevkova, E. V</creatorcontrib><creatorcontrib>Kachanova, M. V</creatorcontrib><creatorcontrib>Zabolotneva, Yu. A</creatorcontrib><creatorcontrib>Tarasov, S. A</creatorcontrib><creatorcontrib>Dugina, Yu. L</creatorcontrib><creatorcontrib>Sergeeva, S. A</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Petrov, V. I</au><au>Babaeva, A. R</au><au>Cherevkova, E. V</au><au>Kachanova, M. V</au><au>Zabolotneva, Yu. A</au><au>Tarasov, S. A</au><au>Dugina, Yu. L</au><au>Sergeeva, S. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficiency and Safety of Long-Term Artrofoon Treatment in Rheumatoid Arthritis</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>148</volume><issue>3</issue><spage>486</spage><epage>488</epage><pages>486-488</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><coden>BEXBAN</coden><abstract>In patients with rheumatoid arthritis, prolongation of artrofoon therapy to 2 years led to maintenance of the positive clinical effect attained after 6-month treatment. Moreover, significant improvement was observed by some parameters (integral pain intensity, swelling index, Ritchie articular index, morning stiffness, and articular score). No side effects related to artrofoon treatment were observed throughout the treatment period in the main group. The results indicate high efficiency and good tolerability of the preparation and attest to advisability of its long-term use.</abstract><cop>Boston</cop><pub>Boston : Springer US</pub><pmid>20396719</pmid><doi>10.1007/s10517-010-0743-4</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-4888
ispartof Bulletin of experimental biology and medicine, 2009-09, Vol.148 (3), p.486-488
issn 0007-4888
1573-8221
language eng
recordid cdi_proquest_miscellaneous_733890996
source Springer Link
subjects Adult
Aged
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Antirheumatic Agents - adverse effects
Antirheumatic Agents - therapeutic use
Arthritis, Rheumatoid - drug therapy
artrofoon
Biomedical and Life Sciences
Biomedicine
Cell Biology
Female
Humans
Internal Medicine
Laboratory Medicine
Male
Middle Aged
Pathology
proinflammatory cytokines
rheumatoid arthritis
Treatment Outcome
tumor necrosis factor-a
title Efficiency and Safety of Long-Term Artrofoon Treatment in Rheumatoid Arthritis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A59%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficiency%20and%20Safety%20of%20Long-Term%20Artrofoon%20Treatment%20in%20Rheumatoid%20Arthritis&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Petrov,%20V.%20I&rft.date=2009-09-01&rft.volume=148&rft.issue=3&rft.spage=486&rft.epage=488&rft.pages=486-488&rft.issn=0007-4888&rft.eissn=1573-8221&rft.coden=BEXBAN&rft_id=info:doi/10.1007/s10517-010-0743-4&rft_dat=%3Cproquest_cross%3E1964606521%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c346t-aa92b9219857a868d30d83808318acbea38550dd451cc02ba522860c317b8bd33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=213386697&rft_id=info:pmid/20396719&rfr_iscdi=true